[Getnews] C&R Research and Rophibio join forces for global biosimilar clinical trials
C&R Research (CEO Moon-Tae Yoon), a contract research organization (CRO), and Rophibio (CEO Sung-Ho Hahm) conducted major national clinical trials for Rophibio’s “RBS-001” global biosimilar at C&R Research headquarters. It was announced on the 21st that an agreement ceremony was held.
C&R Research has been entrusted with this clinical trial by Rophibio and will conduct clinical trials simultaneously in a total of 8 countries, including Korea, the United States, Japan, and 5 European countries, and will take on the overall role of clinical trials conducted in each country.
